soyasaponin bb has been researched along with Invasiveness, Neoplasm in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Elwakeel, A; Kalra, RS; Kaul, SC; Omar, A; Putri, J; Wadhwa, R | 1 |
Chou, YT; Hsieh, SL; Lee, OK; Sung, PL; Wang, PH; Wen, KC; Wu, CW | 1 |
Chang, WW; Hsu, CC; Lin, TW; Lo, WH; Tsai, YC; Wang, PH; Wu, CY | 1 |
Chang, WW; Lin, TW; Tsai, YC; Wang, PH; Yu, CY | 1 |
4 other study(ies) available for soyasaponin bb and Invasiveness, Neoplasm
Article | Year |
---|---|
Soyasapogenol-A targets CARF and results in suppression of tumor growth and metastasis in p53 compromised cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Neoplasm Invasiveness; Oleanolic Acid; RNA-Binding Proteins; Saponins; Signal Transduction; Transcriptional Activation; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2020 |
α2,3-sialyltransferase type I regulates migration and peritoneal dissemination of ovarian cancer cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta-Galactoside alpha-2,3-Sialyltransferase; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Drug Synergism; ErbB Receptors; Female; Humans; Immunohistochemistry; Immunoprecipitation; Kaplan-Meier Estimate; Mice; Mice, Inbred C57BL; Microarray Analysis; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Oleanolic Acid; Ovarian Neoplasms; Ovary; Peritoneal Neoplasms; Peritoneum; Prognosis; Protein Kinase Inhibitors; Saponins; Sialyltransferases; Signal Transduction; Survival Rate | 2017 |
Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids.
Topics: beta-Galactoside alpha-2,3-Sialyltransferase; Breast Neoplasms; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Matrix; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Oleanolic Acid; Saponins; Sialic Acids; Sialyltransferases | 2005 |
Soyasaponin I decreases the expression of alpha2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells.
Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Membrane; Cell Movement; Extracellular Matrix; Flow Cytometry; Glycine max; Glycosylation; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Neoplasm Invasiveness; Neoplasm Metastasis; NIH 3T3 Cells; Oleanolic Acid; Saponins; Sialic Acids | 2006 |